Table 3.
Clinical outcomes of the study population during hospitalization, according to the three study groups
| Entire study population (N = 60) |
Group A (N = 26) |
Group B (N = 24) |
Group C (N = 7) |
P* | |
|---|---|---|---|---|---|
| Clinical failure | 22 (37) | 10 (39) | 11 (46) | 1 (14) | 0.320 |
| Endotracheal intubation | 11 (18) | 4 (15) | 6 (25) | 1 (14) | 0.647 |
| ECMO | 3 (4.6) | 1 (3.8) | 2 (8.4) | 0 | 0.789 |
| In-hospital mortality | 21 (35) | 9 (35) | 11 (46) | 1 (14) | 0.298 |
P* = among three group; ECMO: extra-corporeal membrane oxygenation; Group A: patients with either pneumonia or acute heart failure as trigger of acute respiratory failure (ARF): Group B: patients with acute exacerbation of fibrosis as trigger of ARF; Group C: patients with other triggers of ARF.